Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Diabetes Sci Technol ; 14(5): 908-911, 2020 09.
Article in English | MEDLINE | ID: mdl-31762302

ABSTRACT

The Onduo Virtual Diabetes Clinic (VDC) telehealth technology/care model for adults with type 2 diabetes (T2D) combines connected devices, remote lifestyle coaching, and clinical support with a mobile App. Key differentiating program features are the availability of live video consultations with board-certified endocrinologists for medication management and real-time continuous glucose monitor use for higher-risk participants. Preliminary data (n = 740) suggest that participation was associated with a significant improvement in HbA1c with up to 6 months follow-up in those not meeting treatment targets. HbA1c decreased by 2.3% ± 1.9%, 0.7% ± 1.0%, and 0.2% ± 0.8% across baseline categories of >9.0%, 8.0%-9.0% and 7.0% to <8.0%, respectively (all P < .001). These findings suggest that the VDC has potential to support individuals with T2D and their clinicians in diabetes management between office visits.


Subject(s)
Ambulatory Care Facilities , Blood Glucose Self-Monitoring , Diabetes Mellitus, Type 2/therapy , Endocrinology , Glycemic Control , Hypoglycemic Agents/therapeutic use , Monitoring, Ambulatory , Risk Reduction Behavior , Telemedicine , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diagnosis , Female , Glycated Hemoglobin/metabolism , Glycemic Control/adverse effects , Humans , Hypoglycemic Agents/adverse effects , Male , Middle Aged , Mobile Applications , Predictive Value of Tests , Time Factors , Treatment Outcome , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...